Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2019 Nov 5;10:2517. doi: 10.3389/fmicb.2019.02517

Corrigendum: A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis

Patricia B da Silva 1,*, Eduardo Sinésio de Freitas 1, Mariana Cristina Solcia 1, Paula Carolina de Souza 1, Monize Martins da Silva 2, Alzir Azevedo Batista 2, Carlos E Eismann 3, Ana Marta C M Rolisola 3, Amauri A Menegário 3, Rosilene Fressatti Cardoso 4, Marlus Chorilli 1, Fernando R Pavan 1,*
PMCID: PMC6848849  PMID: 31736932

In the original article, we neglected to include the funder Grant # 2018/00163-0 São Paulo Research Foundation (FAPESP), to for all authors.

The FUNDING is: “This research was funded by grant #2013/14957-5, grant #2013/09265-7 and grant #2018/00163-0 São Paulo Research Foundation (FAPESP) by the Coordination for the Improvement of Higher Education Personnel (CAPES) together with the Post-Doctoral National Program (PNPD), the Programa de Apoio ao Desenvolvimento Científico (PADC) of School of Pharmaceutical Sciences/UNESP, Brazil and the authors thank UNESP for the data of the dissertation (Freitas, 2015).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

References

  1. Freitas E. S. (2015). Nanoencapsulação De Compostos De Rutênio, Análise De Sua Atividade Anti-Mycobacterium Tuberculosis E Biodisponibilidade Oral. Ph.D. thesis, São Paulo State University, São Paulo. [Google Scholar]

Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES